drugset / Trial / NCT00144144

A Study on Ca Blocker Versus AII Antagonists in Hypertension With Type 2 Diabetes

NCT00144144

Phase 4 Unknown 300 enrolled Advanced-J Japan Heart Foundation · collab
RandomizedParallel-groupOpen-labelTreatment

Summary

The antihypertensive effect of the increased dose of angiotensin II receptor blocker (AII antagonist) is compared with that of the additional combined use of amlodipine in hypertensive patients with Type 2 diabetes mellitus, who have been treated with AII antagonist, the antihypertensive effect of which has been inadequate.

Timeline

Start
2004-09
Primary completion
Completion
2008-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Amlodipine Other / unclassified